Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Elisabet Rosell-Vives is active.

Publication


Featured researches published by Elisabet Rosell-Vives.


European Journal of Immunology | 1994

Isolation of tumor cell-specific single-chain Fv from immunized mice using phage-antibody libraries and the re-construction of whole antibodies from these antibody fragments *

Catherine A. Kettleborough; Keith H. Ansell; Richard W. Allen; Elisabet Rosell-Vives; Detlef Gussow; Mary M. Bendig


Archive | 2004

Urea derivatives and their use as tyrosinkinase inhibitors

Günter Hoelzemann; Karl-August Ackermann; Wolfgang Staehle; Alfred Jonczyk; Wilfried Rautenberg; Helerie Crassier; Francesc Mitjans; Elisabet Rosell-Vives; Jaume Adan; Marta Soler Riera


Archive | 2005

4-amino-5-oxo-8-phenyl-5h-pyrido[2,3-d]pyrimidine derivatives as tyrosine kinase and raf kinase inhibitors for the treatment of tumours

Guenter Hoelzemann; Karl-August Ackermann; Helene Crassier; Alfred Jonczyk; Wilfried Rautenberg; Gema Tarrason; Elisabet Rosell-Vives; Jaume Adan; Claudia Cases


Archive | 2005

IMIDAZOL DERIVATIVES AS TYROSINE KINASE INHIBITORS

Günter Hölzemann; Helene Crassier; Alfred Jonczyk; Wolfgang Stähle; Arne Sutter; Wilfried Rautenberg; Francesc Mitjans; Elisabet Rosell-Vives; Jaume Adan; Riera Marta Soler


Archive | 1999

Use of the antibody 271.14d9.f8 (dsm acc2331) to inhibit in vitro alphavbeta6-integrin attachment to fibronectin

Simon Goodman; Beate Diefenbach; Francesc Mitjans; Ana Carceller; Elisabet Rosell-Vives


Archive | 2008

Imidazole derivatives as tyrosine kinase inhibitors

Guenter Holzemann; Alfred Jonczyk; Arne Sutter; Francesc Mitjans; Jaume Adan; Helene Crassier; Wolfgang Stähle; Wilfried Rautenberg; Elisabet Rosell-Vives; Marta Soler Riera


Archive | 2005

Derives d'imidazol comme inhibiteur de la tyrosine kinase

Günter Hölzemann; Helene Crassier; Alfred Jonczyk; Wolfgang Stähle; Arne Sutter; Wilfried Rautenberg; Francesc Mitjans; Elisabet Rosell-Vives; Jaume Adan; Riera Marta Soler


Archive | 2005

Imidazolderivate als hemmer von tyrosinkinase

Jaume Adan; Helene Crassier; Guenter Hoelzemann; Alfred Jonczyk; Francesc Mitjans; Wilfried Rautenberg; Elisabet Rosell-Vives; Riera Marta Soler; Wolfgang Staehle; Arne Sutter


Archive | 2005

4-AMINO-5-OXO-8-PHENYL-5H-PYRIDO-Ä2,3-DÜ-PYRIMIDIN-DERIVATE ALS INHIBITOREN DER TYROSINKINASEN UND DER RAF-KINASEN ZUR BEHANDLUNG VON TUMOREN

Guenter Hoelzemann; Karl-August Ackermann; Helene Crassier; Alfred Jonczyk; Wilfried Rautenberg; Gema Tarrason; Elisabet Rosell-Vives; Jaume Adan; Claudia Cases


Archive | 2005

4-amino-5-oxo-8-phenyl-5h-pyrido-ä2,3-dü-pyrimidin-derivate als inhibitoren der tyrosinkinasen und der raf-kinasen zur behandlung von tumoren 4-amino-5-oxo-8-phenyl-5h-pyrido-ä2,3-dü-pyrimidine derivatives as inhibitors of tyrosine kinases and the raf kinases for the treatment of tumors

Guenter Hoelzemann; Karl-August Ackermann; Helene Crassier; Alfred Jonczyk; Wilfried Rautenberg; Gema Tarrason; Elisabet Rosell-Vives; Jaume Adan; Claudia Cases

Collaboration


Dive into the Elisabet Rosell-Vives's collaboration.

Researchain Logo
Decentralizing Knowledge